ABBV

Fresh hope for Covid-19 patients as AbbVie (ABBV) leads studies on HIV drug

6 years ago

For some of the leading drugmakers, currently, the first priority is to find an effective treatment for Covid-19, which was…

AbbVie (ABBV) Q4 earnings preview: Generic competition might weigh on results

6 years ago

With only a few weeks left for closing the high-value acquisition of Allergan, AbbVie (NYSE: ABBV) is busy doing the…

AbbVie (NYSE: ABBV) Q3 profit dips 31% but beats estimates

6 years ago

AbbVie Inc. (NYSE: ABBV) reported a 31% dip in earnings for the third quarter of 2019 due to higher costs…